Skip to main content
. 2021 Oct 6;46(6):250. doi: 10.3892/or.2021.8201

Figure 6.

Figure 6.

Effect of the knockdown of MBD2 and EZH2 on the apoptosis of CRC SW480 and HCT116 cells. Flow cytometry was used to detect the effect of the knockdown of MBD2, (A) EZH2, (B) MBD2 and EZH2 (C) and control group si-NC (D) on apoptosis of SW480 cells. Flow cytometry was used to detect the effect of the knockdown od MBD2, (E) EZH2, (F) MBD2 and EZH2 (G) and control group si-NC (H) on apoptosis of HCT116 cells. Statistical analysis of the knockdown of MBD2 and EZH2 on the percentage of apoptotic cells of SW480 (I) and HCT116. (J) *P<0.05, **P<0.01, ***P<0.001 vs. si-NC. CRC, colorectal cancer; MBD2, methyl-CpG binding domain protein 2; EZH2, enhancer of zeste homolog 2.